Clinical Trial Update: A Study to Evaluate the Efficacy of Tolterodine on Specific Symptoms in Adult Patients With Overactive Bladder. [Phase 4]

View source ↗

Summary

Phase 4 study evaluating tolterodine on specific symptoms in adults with overactive bladder; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Tolterodine (tolterodine)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Urinary Bladder, Overactive | Phase 4 | Status: COMPLETED